This brand name is authorized in Nigeria.
The drug VAMANOL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
0I55128JYK - THEOPHYLLINE ANHYDROUS
|
|
Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output. |
|
2
|
UNII
021SEF3731 - ALBUTEROL SULFATE
|
|
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-2891 | Tablet | Vamanol Tablets_ TAB 2 mg; 120 mg 10 x 10's (in Alu PVC blisters) | Tablet. A white bevel-shaped tablet with “VAMANOL” on one side and breakline on the other. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses 33 RNW-PP-407952 VAMANOL TABLETS SALBUTAMOL + THEOPHYLLINE SALBUTAMOL 2MG THEOPHYLLINE 120MG A4-2891 Drugs Nigerian Products 10X10 POM 1 3/15/2024 TUYIL PHARMACEUTICAL INDUSTRIES LTD, , M.M WAY ILORIN KWARA 8033565739 tuyilpharma18@gmail.com Tuyil Pharmaceutical Industries Limited, 22, New Yidi Road, Ilorin, Kwara State., Nigeria | 28/08/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R03DB04 | Theophylline and adrenergics | R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DB Xanthines and adrenergics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-2891 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.